{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T06:24:48Z","timestamp":1778135088797,"version":"3.51.4"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00592-015-0746-8","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T04:43:41Z","timestamp":1428468221000},"page":"1007-1016","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Is diabetes a hypercoagulable state? A critical appraisal"],"prefix":"10.1007","volume":"52","author":[{"given":"Fulvio","family":"Pomero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo Nicola Dario","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Fenoglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Gianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Dentali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"746_CR1","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa022157","volume":"348","author":"P Prandoni","year":"2003","unstructured":"Prandoni P, Bilora F, Marchiori A et al (2003) An association between atherosclerosis and venous thrombosis. N Engl J Med 348:1435\u20131441","journal-title":"N Engl J Med"},{"key":"746_CR2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2796.2007.01815.x","volume":"262","author":"P Prandoni","year":"2007","unstructured":"Prandoni P (2007) Links between arterial and venous disease. J Intern Med 262:341\u2013350","journal-title":"J Intern Med"},{"key":"746_CR3","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","volume":"292","author":"M Cushman","year":"2004","unstructured":"Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR (2004) Women\u2019s Health Initiative Investigators. Estrogen plus progestin and risk of venous thrombosis. JAMA 292:1573\u20131580","journal-title":"JAMA"},{"key":"746_CR4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/CIRCULATIONAHA.104.521344","volume":"112","author":"H Deguchi","year":"2005","unstructured":"Deguchi H, Pecheniuk NM, Elias DJ et al (2005) High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation 112:893\u2013899","journal-title":"Circulation"},{"key":"746_CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","volume":"65","author":"\u00d8 Lidegaard","year":"2002","unstructured":"Lidegaard \u00d8, Edstr\u00f6m B, Kreiner S (2002) Oral contraceptives and venous thromboembolism: a five-year national case-control study. Contraception 65:187\u2013196","journal-title":"Contraception"},{"key":"746_CR6","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91927-9","volume":"346","author":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1995","unstructured":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995) Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 346:1575\u20131582","journal-title":"Lancet"},{"key":"746_CR7","first-page":"225","volume":"11","author":"MD McColl","year":"2000","unstructured":"McColl MD, Sattar N, Ellison J et al (2000) Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism. Blood Coagul Fibrinolysis 11:225\u2013229","journal-title":"Blood Coagul Fibrinolysis"},{"key":"746_CR8","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1182\/blood-2004-03-0897","volume":"104","author":"J Frederiksen","year":"2004","unstructured":"Frederiksen J, Juul K, Grande P et al (2004) Methylenetetrahydrofolatereductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study. Blood 104:3046\u20133051","journal-title":"Blood"},{"issue":"111","key":"746_CR9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.amjcard.2012.11.026","volume":"1","author":"M Zoni-Berisso","year":"2013","unstructured":"Zoni-Berisso M, Filippi A, Landolina M et al (2013) Frequency, patient characteristics, treatment strategies, and resource usage of atrial fibrillation (from the Italian Survey of Atrial Fibrillation Management [ISAF] study). Am J Cardiol 1(111):705\u2013711","journal-title":"Am J Cardiol"},{"key":"746_CR10","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GY, De Caterina R et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:2719\u20132747","journal-title":"Eur Heart J"},{"key":"746_CR11","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/ATVBAHA.109.189290","volume":"29","author":"JA Heit","year":"2009","unstructured":"Heit JA, Leibson CL, Ashrani AA et al (2009) Is diabetes mellitus an independent risk factor for venous thromboembolism? A population-based case-control study. Arterioscler Thromb Vasc Biol 29:1399\u20131405","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"746_CR12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MAJ.0b013e31818bbb8b","volume":"337","author":"PD Stein","year":"2009","unstructured":"Stein PD, Goldman J, Matta F et al (2009) Diabetes mellitus and risk of venous thromboembolism. Am J Med Sci 337:259\u2013264","journal-title":"Am J Med Sci"},{"key":"746_CR13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00125-005-1715-5","volume":"48","author":"V Petrauskiene","year":"2005","unstructured":"Petrauskiene V, Falk M, Waernbaum I et al (2005) The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia 48:1017\u20131021","journal-title":"Diabetologia"},{"key":"746_CR14","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1055\/s-0037-1614363","volume":"82","author":"E H\u00f8ibraaten","year":"1999","unstructured":"H\u00f8ibraaten E, Abdelnoor M, Sandset PM (1999) Hormone replacement therapy with estradiol and risk of venous thromboembolism-a population-based case-control study. Thromb Haemost 82:1218\u20131221","journal-title":"Thromb Haemost"},{"key":"746_CR15","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/archinte.162.10.1182","volume":"162","author":"AW Tsai","year":"2002","unstructured":"Tsai AW, Cushman M, Rosamond WD et al (2002) Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 162:1182\u20131189","journal-title":"Arch Intern Med"},{"key":"746_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/met.2010.0117","volume":"9","author":"A Vay\u00e1","year":"2011","unstructured":"Vay\u00e1 A, Mart\u00ednez-Triguero ML, Espa\u00f1a F et al (2011) The metabolic syndrome and its individual components: its association with venous thromboembolism in a Mediterranean population. Metab Syndr Relat Disord 9:197\u2013201","journal-title":"Metab Syndr Relat Disord"},{"key":"746_CR17","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1538-7836.2009.03295.x","volume":"7","author":"LM Steffen","year":"2009","unstructured":"Steffen LM, Cushman M, Peacock JM et al (2009) Metabolic syndrome and risk of venous thromboembolism: longitudinal investigation of thromboembolism etiology. J Thromb Haemost 7:746\u2013751","journal-title":"J Thromb Haemost"},{"key":"746_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.thromres.2010.12.005","volume":"127","author":"MN Minno Di","year":"2011","unstructured":"Di Minno MN, Tufano A, Guida A et al (2011) Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thromb Res 127:193\u2013197","journal-title":"Thromb Res"},{"key":"746_CR19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2796.2007.01815.x","volume":"262","author":"P Prandoni","year":"2007","unstructured":"Prandoni P (2007) Links between arterial and venous disease. J Intern Med 262:341\u2013350","journal-title":"J Intern Med"},{"key":"746_CR20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","volume":"117","author":"W Ageno","year":"2008","unstructured":"Ageno W, Becattini C, Brighton T et al (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117:93\u2013102","journal-title":"Circulation"},{"key":"746_CR21","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1538-7836.2012.04707.x","volume":"10","author":"IM Schouwenburg Van","year":"2012","unstructured":"Van Schouwenburg IM, Mahmoodi BK, Veeger NJ et al (2012) Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study. J Thromb Haemost 10:1012\u20131018","journal-title":"J Thromb Haemost"},{"key":"746_CR22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1160\/TH13-01-0048","volume":"110","author":"A Delluc","year":"2013","unstructured":"Delluc A, De Moreuil C, Kerspern H et al (2013) Body mass index, a major confounder to insulin resistance association with unprovoked venous thromboembolism. Results from the EDITH case-control study. Thromb Haemost 110:593\u2013597","journal-title":"Thromb Haemost"},{"key":"746_CR23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11606-010-1340-y","volume":"25","author":"S Dublin","year":"2010","unstructured":"Dublin S, Glazer NL, Smith NL et al (2010) Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med 25:853\u2013858","journal-title":"J Gen Intern Med"},{"key":"746_CR24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/heartjnl-2011-300503","volume":"98","author":"RR Huxley","year":"2012","unstructured":"Huxley RR, Alonso A, Lopez FL et al (2012) Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study. Heart 98:133\u2013138","journal-title":"Heart"},{"key":"746_CR25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","volume":"108","author":"RR Huxley","year":"2011","unstructured":"Huxley RR, Filion KB, Konety S et al (2011) Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 108:56\u201362","journal-title":"Am J Cardiol"},{"key":"746_CR26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijcard.2005.03.003","volume":"105","author":"GY Lip","year":"2005","unstructured":"Lip GY, Varughese GI (2005) Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links. Int J Cardiol 105:319\u2013321","journal-title":"Int J Cardiol"},{"key":"746_CR27","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"BF Gage","year":"2001","unstructured":"Gage BF, Waterman AD, Shannon W et al (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864\u20132870","journal-title":"JAMA"},{"key":"746_CR28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263\u2013272","journal-title":"Chest"},{"key":"746_CR29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1212\/01.wnl.0000267275.68538.8d","volume":"69","author":"Stroke Risk in Atrial Fibrillation Working Group","year":"2007","unstructured":"Stroke Risk in Atrial Fibrillation Working Group (2007) Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 69:546\u2013554","journal-title":"Neurology"},{"key":"746_CR30","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","volume":"154","author":"A Laupacis","year":"1994","unstructured":"Laupacis A (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449\u20131457","journal-title":"Arch Intern Med"},{"key":"746_CR31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","volume":"30","author":"RG Hart","year":"1999","unstructured":"Hart RG, Pearce LA, McBride R et al (1999) Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The stroke prevention in atrial fibrillation (SPAF) investigators. Stroke 30:1223\u20131229","journal-title":"Stroke"},{"key":"746_CR32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.290.8.1049","volume":"290","author":"TJ Wang","year":"2003","unstructured":"Wang TJ, Massaro JM, Levy D et al (2003) A risk score for predicting stroke or death in individuals with newonset atrial fibrillation in the community: the Framingham Heart Study. J Am Med Assoc 290:1049\u20131056","journal-title":"J Am Med Assoc"},{"key":"746_CR33","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/archinte.158.12.1316","volume":"158","author":"Atrial fibrillation investigators","year":"1998","unstructured":"Atrial fibrillation investigators (1998) Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med 158:1316\u20131320","journal-title":"Arch Intern Med"},{"key":"746_CR34","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0002-9149(98)00419-6","volume":"82","author":"K Seidl","year":"1998","unstructured":"Seidl K, Hauer B, Schwick NG et al (1998) Risk of thromboembolic events in patients with atrial flutter. Am J Cardiol 82:580\u2013583","journal-title":"Am J Cardiol"},{"key":"746_CR35","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jama.279.16.1273","volume":"279","author":"The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators","year":"1998","unstructured":"The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators (1998) Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. JAMA 279:1273\u20131277","journal-title":"JAMA"},{"key":"746_CR36","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archinte.1990.00390160077016","volume":"150","author":"P Petersen","year":"1990","unstructured":"Petersen P, Kastrup J, Helweg-Larsen S et al (1990) Risk factors for thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Arch Intern Med 150:819\u2013821","journal-title":"Arch Intern Med"},{"key":"746_CR37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0002-9149(98)00247-1","volume":"82","author":"WS Aronow","year":"1998","unstructured":"Aronow WS, Ahn C, Kronzon I et al (1998) Risk factors for new thromboembolic stroke in patients \u226462\u00a0years of age with chronic atrial fibrillation. Am J Cardiol 82:119\u2013121","journal-title":"Am J Cardiol"},{"key":"746_CR38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/clc.4960270111","volume":"27","author":"C Stollberger","year":"2004","unstructured":"Stollberger C, Chnupa P, Abzieher C et al (2004) Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study. Clin Cardiol 27:40\u201346","journal-title":"Clin Cardiol"},{"key":"746_CR39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11739-011-0582-y","volume":"7","author":"MN Minno Di","year":"2012","unstructured":"Di Minno MN, Tufano A, Ageno W et al (2012) Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update. Intern Emerg Med 7:9\u201313","journal-title":"Intern Emerg Med"},{"key":"746_CR40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/157339909789804404","volume":"5","author":"S Nomura","year":"2009","unstructured":"Nomura S (2009) Dynamic role of microparticles in type 2 diabetes mellitus. Curr Diabetes Rev 5:245\u2013251","journal-title":"Curr Diabetes Rev"},{"key":"746_CR41","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.2337\/diacare.24.8.1476","volume":"24","author":"AI Vinik","year":"2001","unstructured":"Vinik AI, Erbas T, Park TS et al (2001) Platelet dysfunction in type 2 diabetes. Diabetes Care 24:1476\u20131485","journal-title":"Diabetes Care"},{"key":"746_CR42","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","volume":"357","author":"G Dav\u00ec","year":"2007","unstructured":"Dav\u00ec G, Patrono C (2007) Platelet Activation and atherothrombosis. N Engl J Med 357:2482\u20132494","journal-title":"N Engl J Med"},{"key":"746_CR43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.thromres.2011.11.020","volume":"129","author":"MN Minno Di","year":"2012","unstructured":"Di Minno MN, Lupoli R, Palmieri NM et al (2012) Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update. Thromb Res 129:341\u2013344","journal-title":"Thromb Res"},{"key":"746_CR44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2362.1992.tb01510.x","volume":"22","author":"D Tsch\u00f6pe","year":"1992","unstructured":"Tsch\u00f6pe D, Schwippert B, Schettler B et al (1992) Increased GPIIB\/IIIA expression and altered DNA-ploidy pattern in megakaryocytes of diabetic BB-rats. Eur J Clin Investig 22:591\u2013598","journal-title":"Eur J Clin Investig"},{"key":"746_CR45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/diab.39.2.241","volume":"39","author":"PD Winocour","year":"1990","unstructured":"Winocour PD, Bryszewska M, Watala C et al (1990) Reduced membrane fluidity in platelets from diabetic patients. Diabetes 39:241\u2013244","journal-title":"Diabetes"},{"key":"746_CR46","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0026-0495(98)90034-8","volume":"47","author":"E Iwase","year":"1998","unstructured":"Iwase E, Tawata M, Aida K et al (1998) A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus. Metabolism 47:699\u2013705","journal-title":"Metabolism"},{"key":"746_CR47","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood.V65.1.156.156","volume":"65","author":"G Minno Di","year":"1985","unstructured":"Di Minno G, Silver MJ, Cerbone AM et al (1985) Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. Blood 65:156\u2013162","journal-title":"Blood"},{"key":"746_CR48","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.thromres.2011.05.017","volume":"128","author":"MN Minno Di","year":"2011","unstructured":"Di Minno MN, Pezzullo S, Palmieri V et al (2011) Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis. Thromb Res 128:e43\u2013e48","journal-title":"Thromb Res"},{"key":"746_CR49","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1055\/s-0038-1648993","volume":"72","author":"M Steiner","year":"1994","unstructured":"Steiner M, Reinhardt KM, Krammer B et al (1994) Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 72:979\u2013984","journal-title":"Thromb Haemost"},{"key":"746_CR50","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1172\/JCI115014","volume":"87","author":"R Bucala","year":"1991","unstructured":"Bucala R, Tracey KJ, Cerami A (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Investig 87:432\u2013438","journal-title":"J Clin Investig"},{"key":"746_CR51","first-page":"950","volume":"95","author":"JM Gerrard","year":"1980","unstructured":"Gerrard JM, Stuart MJ, Rao GH et al (1980) Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med 95:950\u2013958","journal-title":"J Lab Clin Med"},{"key":"746_CR52","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615\u20131625","journal-title":"Diabetes"},{"key":"746_CR53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF00569929","volume":"30","author":"M Selva La","year":"1993","unstructured":"La Selva M, Beltramo E, Passera P et al (1993) The role of endothelium in the pathogenesis of diabetic microangiopathy. Acta Diabetol 30:190\u2013200","journal-title":"Acta Diabetol"},{"key":"746_CR54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00592-012-0412-3","volume":"50","author":"F Piarulli","year":"2013","unstructured":"Piarulli F, Sartore G, Lapolla A (2013) Glyco-oxidation and cardiovascularcomplications in type 2 diabetes: a clinical update. Acta Diabetol 50:101\u2013110","journal-title":"Acta Diabetol"},{"key":"746_CR55","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1182\/blood-2003-08-2804","volume":"103","author":"JA Coppinger","year":"2004","unstructured":"Coppinger JA, Cagney G, Toomey S et al (2004) Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103:2096\u20132104","journal-title":"Blood"},{"key":"746_CR56","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1538-7836.2007.02366.x","volume":"5","author":"DL Sauls","year":"2007","unstructured":"Sauls DL, Banini AE, Boyd LC et al (2007) Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes. J Thromb Haemost 5:638\u2013639","journal-title":"J Thromb Haemost"},{"key":"746_CR57","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1210\/jc.2007-0933","volume":"92","author":"G Boden","year":"2007","unstructured":"Boden G, Vaidyula VR, Homko C et al (2007) Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose. J Clin Endocrinol Metab 92:4352\u20134358","journal-title":"J Clin Endocrinol Metab"},{"key":"746_CR58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1253\/circj.CJ-09-0818","volume":"74","author":"A Breitenstein","year":"2010","unstructured":"Breitenstein A, Tanner FC, Luscher TF (2010) Tissue factor and cardiovascular disease: quo vadis? Circ J 74:3\u201312","journal-title":"Circ J"},{"key":"746_CR59","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2337\/diabetes.48.5.1156","volume":"48","author":"AK Rao","year":"1999","unstructured":"Rao AK, Chouhan V, Chen X et al (1999) Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes 48:1156\u20131161","journal-title":"Diabetes"},{"key":"746_CR60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0168-8227(97)01384-3","volume":"36","author":"T Hirano","year":"1997","unstructured":"Hirano T, Kashiwazaki K, Moritomo Y et al (1997) Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients. Diabetes Res Clin Pract 36:11\u201318","journal-title":"Diabetes Res Clin Pract"},{"key":"746_CR61","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00592-013-0543-1","volume":"51","author":"G Daniele","year":"2014","unstructured":"Daniele G, Guardado Mendoza R et al (2014) The inflammatory status score including IL-6, TNF-\u03b1, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 51:123\u2013131","journal-title":"Acta Diabetol"},{"key":"746_CR62","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0038-1649589","volume":"70","author":"MG Conlan","year":"1993","unstructured":"Conlan MG, Folsom AR, Finch A et al (1993) Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) study. Thromb Haemost 70:380\u2013385","journal-title":"Thromb Haemost"},{"key":"746_CR63","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2337\/dc08-0282","volume":"31","author":"A Undas","year":"2008","unstructured":"Undas A, Wiek I, Stepien E et al (2008) Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care 31:1590\u20131595","journal-title":"Diabetes Care"},{"key":"746_CR64","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02369355","volume":"38","author":"B Myrup","year":"1995","unstructured":"Myrup B, Rossing P, Jensen T et al (1995) Procoagulant activity and intimal dysfunction in IDDM. Diabetologia 38:73\u201378","journal-title":"Diabetologia"},{"key":"746_CR65","first-page":"470","volume":"29","author":"EJ Dunn","year":"2004","unstructured":"Dunn EJ, Ari\u00ebns RA (2004) Fibrinogen and fibrin clot structure in diabetes. Herz 29:470\u2013479","journal-title":"Herz"},{"key":"746_CR66","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2337\/diacare.20.8.1252","volume":"20","author":"M Eliasson","year":"1997","unstructured":"Eliasson M, Roder ME, Dinesen B et al (1997) Proinsulin, intact insulin, and fibrinolytic variables and fibrinogen in healthy subjects. Diabetes Care 20:1252\u20131255","journal-title":"Diabetes Care"},{"key":"746_CR67","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.thromres.2009.05.020","volume":"124","author":"D Hern\u00e1ndez-Espinosa","year":"2009","unstructured":"Hern\u00e1ndez-Espinosa D, Ord\u00f3\u00f1ez A, Mi\u00f1ano A, Mart\u00ednez-Mart\u00ednez I, Vicente V, Corral J (2009) Hyperglycaemia impairs antithrombin secretion: possible contribution to the thrombotic risk of diabetes. Thromb Res 124:483\u2013489","journal-title":"Thromb Res"},{"key":"746_CR68","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-0038-1647262","volume":"64","author":"A Ceriello","year":"1990","unstructured":"Ceriello A, Quatraro A, Dello Russo P et al (1990) Protein C deficiency in insulin-dependent diabetes: a hyperglycemia-related phenomenon. Thromb Haemost 64:104\u2013107","journal-title":"Thromb Haemost"},{"key":"746_CR69","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00279921","volume":"28","author":"A L\u00fctjens","year":"1985","unstructured":"L\u00fctjens A, teVelde AA, vdVeen EA et al (1985) Glycosylation of human fibrinogen in vivo. Diabetologia 28:87\u201389","journal-title":"Diabetologia"},{"key":"746_CR70","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.ATV.8.1.68","volume":"8","author":"J Auwerx","year":"1988","unstructured":"Auwerx J, Bouillon R, Collen D et al (1988) Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 8:68\u201372","journal-title":"Arteriosclerosis"},{"key":"746_CR71","doi-asserted-by":"crossref","first-page":"20ra15","DOI":"10.1126\/scitranslmed.3000292","volume":"2","author":"P Kishore","year":"2010","unstructured":"Kishore P, Li W, Tonelli J et al (2010) Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages. Sci Transl Med 2:20ra15","journal-title":"Sci Transl Med"},{"key":"746_CR72","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.CIR.0000052617.91920.FD","volume":"107","author":"S Devaraj","year":"2003","unstructured":"Devaraj S, Xu DY, Jialal I (2003) C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells. Implications for the metabolic syndrome and atherothrombosis. Circulation 107:398\u2013404","journal-title":"Circulation"},{"key":"746_CR73","doi-asserted-by":"crossref","first-page":"C1391","DOI":"10.1152\/ajpcell.1999.276.6.C1391","volume":"276","author":"T Sakamoto","year":"1999","unstructured":"Sakamoto T, Woodcock-Mitchell J, Marutsuka K et al (1999) TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes. Am J Physiol 276:C1391\u2013C1397","journal-title":"Am J Physiol"},{"key":"746_CR74","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.CIR.89.1.321","volume":"89","author":"TK Nordt","year":"1994","unstructured":"Nordt TK, Schneider DJ, Sobel BE (1994) Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease. Circulation 89:321\u2013330","journal-title":"Circulation"},{"key":"746_CR75","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.mca.0000076512.29238.2a","volume":"14","author":"DM Kendall","year":"2003","unstructured":"Kendall DM, Sobel BE, Coulston AM et al (2003) The insulin resistance syndrome and coronary artery disease. Coron Artery Dis 14:335\u2013348","journal-title":"Coron Artery Dis"},{"key":"746_CR76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s005920170016","volume":"38","author":"A Pandolfi","year":"2001","unstructured":"Pandolfi A, Giaccari A, Cilli C et al (2001) Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol 38:71\u201376","journal-title":"Acta Diabetol"},{"key":"746_CR77","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/01.ATV.18.11.1716","volume":"18","author":"EJ Giltay","year":"1998","unstructured":"Giltay EJ, Elbers JMH, Gooren LJG et al (1998) Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women. Modulation by cross-sex hormone administration. Arterioscler Thromb Vasc Biol 18:1716\u20131722","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"746_CR78","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jama.283.2.221","volume":"283","author":"JB Meigs","year":"2000","unstructured":"Meigs JB, Mittleman MA, Nathan DM et al (2000) Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham offspring study. J Am Med Assoc 283:221\u2013228","journal-title":"J Am Med Assoc"},{"key":"746_CR79","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.thromres.2009.06.018","volume":"124","author":"MN Minno Di","year":"2009","unstructured":"Di Minno MN, Palmieri V, Lombardi G et al (2009) Lack of change in insulin levels as a biological marker of PAI-1 lowering in GH-deficient adults on r-HGH replacement therapy. Thromb Res 124:711\u2013713","journal-title":"Thromb Res"},{"key":"746_CR80","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00125-011-2301-7","volume":"55","author":"K Hess","year":"2012","unstructured":"Hess K, Alzahrani SH, Mathai M et al (2012) A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3. Diabetologia 55:1103\u20131113","journal-title":"Diabetologia"},{"key":"746_CR81","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00125-014-3267-z","volume":"57","author":"K Hess","year":"2014","unstructured":"Hess K, Alzahrani SH, Price JF et al (2014) Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3. Diabetologia 57:1737\u20131741","journal-title":"Diabetologia"},{"key":"746_CR82","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1161\/01.CIR.96.9.3180","volume":"96","author":"P Carmeliet","year":"1997","unstructured":"Carmeliet P, Moons L, Lijnen R et al (1997) Inhibitor role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation 96:3180\u20133191","journal-title":"Circulation"},{"key":"746_CR83","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/eurheartj\/ehp556","volume":"31","author":"A Squizzato","year":"2010","unstructured":"Squizzato A, Galli M, Romualdi E et al (2010) Statins, fibrates, and venous thromboembolism: a meta-analysis. Eur Heart J 31:1248\u20131256","journal-title":"Eur Heart J"},{"key":"746_CR84","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","volume":"355","author":"Pulmonary Embolism Prevention (PEP) Trial Collaborative Group","year":"2000","unstructured":"Pulmonary Embolism Prevention (PEP) Trial Collaborative Group (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 355:1295\u20131302","journal-title":"Lancet"},{"key":"746_CR85","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","volume":"367","author":"TA Brighton","year":"2012","unstructured":"Brighton TA, Eikelboom JW, Mann K et al (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367:1979\u20131987","journal-title":"N Engl J Med"},{"key":"746_CR86","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","volume":"366","author":"C Becattini","year":"2012","unstructured":"Becattini C, Agnelli G, Schenone A et al (2012) Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 366:1959\u20131967","journal-title":"N Engl J Med"},{"key":"746_CR87","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/CIRCULATIONAHA.114.008828","volume":"130","author":"J Simes","year":"2014","unstructured":"Simes J, Becattini C, Agnelli G et al (2014) Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation 130:1062\u20131071","journal-title":"Circulation"},{"key":"746_CR88","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu243","volume":"35","author":"SV Konstantinides","year":"2014","unstructured":"Konstantinides SV, Torbicki A, Agnelli G et al (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35:3033\u20133069","journal-title":"Eur Heart J"},{"issue":"2 Suppl","key":"746_CR89","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","volume":"141","author":"C1 Kearon","year":"2012","unstructured":"Kearon C1, Akl EA, Comerota AJ, Prandoni P et al (2012) Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e419S\u2013e494S","journal-title":"Chest"},{"key":"746_CR90","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383:955\u2013962","journal-title":"Lancet"},{"key":"746_CR91","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1378\/chest.130.5.1390","volume":"130","author":"TI Shireman","year":"2006","unstructured":"Shireman TI, Mahnken JD, Howard PA et al (2006) Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest 130:1390\u20131396","journal-title":"Chest"},{"key":"746_CR92","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.jacc.2014.02.549","volume":"63","author":"EM Hylek","year":"2014","unstructured":"Hylek EM, Held C, Alexander JH et al (2014) Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): predictors, characteristics, and clinical outcomes. J Am Coll Cardiol 63:2141\u20132147","journal-title":"J Am Coll Cardiol"},{"key":"746_CR93","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-014-0123-x","volume":"13","author":"SH Chang","year":"2014","unstructured":"Chang SH, Wu LS, Chiou MJ et al (2014) Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies. Cardiovasc Diabetol 13:123\u2013131","journal-title":"Cardiovasc Diabetol"},{"key":"746_CR94","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1536\/ihj.14-107","volume":"55","author":"B Liu","year":"2014","unstructured":"Liu B, Wang J, Wang G (2014) Beneficial effects of pioglitazone on retardation of persistent atrial fibrillation progression in diabetes mellitus patients. Int Heart J. 55:499\u2013505","journal-title":"Int Heart J."}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-015-0746-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-015-0746-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-015-0746-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T15:47:40Z","timestamp":1598888860000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-015-0746-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,9]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1007\/s00592-015-0746-8","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,9]]}}}